NCT03524534

Brief Summary

This study is a pragmatic randomized clinical trial to determine the effectiveness of two strategies of early follow-up in adults after hospitalization for heart failure: telephone follow-up with a heart failure care manager vs. in-person clinic visit with their primary care provider. The primary outcomes during 30-day follow-up will include readmission for heart failure, death and readmission for any cause. The study team aims to randomly assign 2400 patients during a 15-month period in a 1-to-1 ratio to either an initial structured telephone call with a heart failure care manager or an in-person primary care clinic visit within 7 days of discharge. A secondary goal is to increase the rate of any follow-up within 7 days of discharge to greater than 90 percent among all eligible patients.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,091

participants targeted

Target at P75+ for not_applicable heart-failure

Timeline
Completed

Started Jan 2017

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

May 2, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 15, 2018

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

June 12, 2023

Status Verified

June 1, 2023

Enrollment Period

1.7 years

First QC Date

May 2, 2018

Last Update Submit

June 9, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Readmission for heart failure within 30-days

    To compare 30-day rates of heart failure-related readmission for subjects randomly assigned to initial heart failure care manager telephone visit vs. in-person primary care clinic visit within 7 days after discharge from a heart failure hospitalization.

    30 days after discharge

Secondary Outcomes (3)

  • Readmission for any cause within 30 days

    30 days after discharge

  • Increase in 7-day follow-up rates

    7 days after discharge

  • Death from any cause within 30 days

    30 days after discharge

Study Arms (2)

Telephone Follow-Up Intervention

ACTIVE COMPARATOR
Other: Telephone Call

In-person follow-up intervention

ACTIVE COMPARATOR
Other: In-Person Primary Care Clinical Follow-Up Visit

Interventions

A phone call will take place within 7 days of discharge by a Kaiser Permanente Heart Failure Care Manager from the Kaiser Permanente Heart Failure Chronic Care Management Program.

Telephone Follow-Up Intervention

This will be a standard in-person clinic visit with the subject's primary care physician within 7 days of discharge, with no structured heart failure protocol.

In-person follow-up intervention

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All eligible patients hospitalized for confirmed acute heart failure at a Kaiser Permanente Northern California medical center

You may not qualify if:

  • Planned discharge to a location other than their home. This includes a skilled nursing facility, nursing home or hospice facility.
  • Planned discharge to home with hospice care.
  • End-stage renal disease treated with chronic peritoneal dialysis or hemodialysis.
  • Death during the index hospitalization.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Lee KK, Thomas RC, Tan TC, Leong TK, Steimle A, Go AS. The Heart Failure Readmission Intervention by Variable Early Follow-up (THRIVE) Study: A Pragmatic Randomized Trial. Circ Cardiovasc Qual Outcomes. 2020 Oct;13(10):e006553. doi: 10.1161/CIRCOUTCOMES.120.006553. Epub 2020 Sep 24.

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Officials

  • Alan S. Go, MD

    Kaiser Permanente

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 2, 2018

First Posted

May 15, 2018

Study Start

January 1, 2017

Primary Completion

September 1, 2018

Study Completion

December 1, 2018

Last Updated

June 12, 2023

Record last verified: 2023-06